Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Kapusta Insider Profile
4 Followers
Matthew Kapusta, SVP BD at AngioDynamics, holds 597.91K shares in uniQure (Ticker: QURE), holds 0.00 shares in Decibel Therapeutics (Ticker: DBTX), holds 30.06K shares in AngioDynamics (Ticker: ANGO).
Profitable Transactions
7 out of 12 Profitable Transactions
Average Return
+7.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Kapusta holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Kapusta
Matthew Kapusta's Trading History
AngioDynamics
Nov 19, 2014
SVP BD
Uninformative Sell
23.46K
$267.25K
uniQure
Dec 12, 2024
CEO, Managing Director, Director
Uninformative Buy
1.47M
$10.15M
Decibel Therapeutics
Sep 25, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Matthew Kapusta's performance on stock
You May Also Like
Matthew Kapusta insider profile FAQ
What is the percentage of profitable transactions made by Matthew Kapusta?
The percentage of profitable transactions made by Matthew Kapusta is 58%.
What is the average return per transaction made by Matthew Kapusta?
The average return per transaction made by Matthew Kapusta is 7.50%.
What stocks does Matthew Kapusta hold?
Matthew Kapusta holds: ANGO, QURE, DBTX stocks.
What was Matthew Kapusta’s latest transaction?
Matthew Kapusta latest transaction was an Uninformative Buy of $1.47M.
What was Matthew Kapusta's most profitable transaction?
Matthew Kapusta’s most profitable transaction was an Informative Sell of QURE stock on March 9, 2023. The return on the trade was 74.30%.
What is Matthew Kapusta's role in AngioDynamics?
Matthew Kapusta's role in AngioDynamics is SVP BD.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.